Public filings / BLTE on Yahoo Finance (opens in a new tab)
BLTE: insider buying, 13F holders, analyst moves
Belite Bio Inc - US ADR
A summary of public filings about Belite Bio Inc - US ADR. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold BLTE
Combined reported value $242.5M; 3 sold out since Q1 2026.
Holders among our 100 managers: 0 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| RTW Investments | $110.2M | 0.94% | Unchanged |
| Maverick Capital | $61.0M | 0.55% | New |
| Deerfield Company | $55.0M | 0.57% | Added |
| Duquesne Family Office | $16.3M | 0.38% | Unchanged |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.